Roche plans to make SARS test available in July
Emergency Management Alert, May 14, 2003
Swiss pharmaceuticals group Roche Diagnostics plans to make a test for severe acute respiratory syndrome (SARS) available at cost to laboratories in affected countries by the end of July, the Agence France Press reports.
Roche, working with Asian, German, and Canadian partners, plans to price the first batch at $10 to $15 per test, with results available within an hour at the testing center. The company will submit the test to the U.S. Food and Drug Administration and European regulators for approval.
The test uses Roche's patented polymerase chain reaction technique, which analyzes genetic material to detect diseases or disorders. It requires a Roche instrument called the LightCycler System, which the company says is in wide use throughout the world.
The test could mean that authorities will no longer have to quarantine suspected SARS cases for 10 days before determining whether they actually have the disease. Roche used the same technique to develop an anthrax detection test.
Related Products
Most Popular
- Articles
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Topic: CMS, OESS post new security compliance review information, checklist
- HIPAA Q&A: Answering service messages
- Q/A: Volume requirement for reporting hydration services
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- Are your workforce members texting PHI?
- OB services: Coding inside and outside of the package
- CMS issues IPPS proposed rule for FY 2013
- E-mailed
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Are your workforce members texting PHI?
- Don't let these sentinel events trigger falsely
- Arkansas woman convicted for HIPAA violation
- Reasons for inadequate fluid intake in the elderly
- Q&A tackles coding questions about injections and infusions
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- Searched
